Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
02/2003
02/13/2003CA2455327A1 Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications
02/13/2003CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity
02/13/2003CA2454945A1 Use of oversulfated polysaccharides as inhibitors of hiv
02/13/2003CA2454937A1 Modulators of notch signalling for use in immunotherapy
02/13/2003CA2453831A1 Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine
02/13/2003CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
02/13/2003CA2453178A1 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
02/13/2003CA2452524A1 Use of lhrh-antagonists for the improvement of t-cell mediated immunity
02/13/2003CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer
02/13/2003CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
02/12/2003EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
02/12/2003EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses
02/12/2003EP1283045A1 Drug and food containing glucomannan for inhibiting IgE antibody
02/12/2003EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor
02/12/2003EP1282700A1 Neuronal serine-threonine protein kinase
02/12/2003EP1282699A2 Splice-region antisense composition and method
02/12/2003EP1282685A2 Pluripotent cells comprising allogenic nucleus and mitochondria
02/12/2003EP1282646A2 Human monoclonal antibodies to dendritic cells
02/12/2003EP1282643A2 Anti-inflammatory compounds and uses thereof
02/12/2003EP1282626A2 Polyketide derivatives
02/12/2003EP1282624A1 Crf receptor antagonists and methods relating thereto
02/12/2003EP1282622A1 Crf receptor antagonists and methods relating thereto
02/12/2003EP1282617A1 Hydantoin derivatives with affinity for somatostatin receptors
02/12/2003EP1282614A1 Hydroxamic acid derivatives
02/12/2003EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
02/12/2003EP1282600A1 Inhibitors of dipeptidyl peptidase iv
02/12/2003EP1282599A1 Disulfide derivatives useful for treating allergic diseases
02/12/2003EP1282592A2 Use of amines
02/12/2003EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders
02/12/2003EP1282441A2 Treating t-cell mediated diseases by modulating dr6 activity
02/12/2003EP1282430A2 Immune response modulation
02/12/2003EP1282427A2 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection
02/12/2003EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
02/12/2003EP1282424A1 compositions for enhancing the immune response
02/12/2003EP1282395A1 Use of ellagic acid as anti-pollution cosmetic agent
02/12/2003EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells
02/12/2003EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
02/12/2003EP0871456B1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
02/12/2003EP0770079B1 Heterobicyclic derivatives
02/12/2003CN1396927A Method for preparing polypeptide soluble in aqueous solvent in absence of detergent
02/12/2003CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
02/12/2003CN1396922A Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid
02/12/2003CN1396918A Formulation for protection against oxidative stress containging benzofuranone derivatives
02/12/2003CN1396910A Use of vitamin D-derivatives in treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives
02/12/2003CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease
02/12/2003CN1396832A Pre-transplant accommodated organs resistant to anti-donor immunity
02/12/2003CN1396823A Electrospun pharmaceutical compositions
02/12/2003CN1395964A Medical usage of simonder wood oil
02/12/2003CN1101228C Treatment of conditions and disease
02/12/2003CN1101216C Health-care pilose antler-pollen food and its preparing process
02/12/2003CN1101215C Health-care tendrilled fritillary bulb-polleen food and its preparing process
02/12/2003CN1101190C HIV protease inhibitor combination medicine
02/11/2003US6518316 Cytokine production and tyrosine kinase inhibitors
02/11/2003US6518306 PDE4 inhibitors particularly in regards to treating allergic and inflammatory diseases
02/11/2003US6518291 Inosine-5'-monophosphate dehydrogenase inhibitors
02/11/2003US6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
02/11/2003US6518286 Compounds
02/11/2003US6518283 Squaric acid derivatives
02/11/2003US6518277 Disrupting leukocyte function
02/11/2003US6518276 Treating a p38 mediated disorders
02/11/2003US6518265 1H-imidazopyridine derivatives
02/11/2003US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders
02/11/2003US6518253 Treatment of viral infections using the L-isomer of ribavirin
02/11/2003US6518239 Dry powder compositions having improved dispersivity
02/11/2003US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of
02/11/2003US6517889 Eliminating or minimizing coating material located within openings; contacting with coating solution then running and rotating a thread through the lumen
02/11/2003CA2162880C Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
02/11/2003CA2125476C 20-methyl-substituted vitamin d derivatives
02/11/2003CA2041818C Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers
02/06/2003WO2003010315A1 Abca7 splicing variant
02/06/2003WO2003010310A1 Method of examining allergic disease
02/06/2003WO2003010299A1 Probiotic lactobacillus casei strains
02/06/2003WO2003010298A1 'probiotic lactobacillus salivarius strains
02/06/2003WO2003010297A1 Probiotic bifidobacterium strains
02/06/2003WO2003010290A2 Novel class ii cytokine receptors and uses thereof
02/06/2003WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
02/06/2003WO2003010281A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
02/06/2003WO2003010201A2 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003WO2003010200A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
02/06/2003WO2003010188A1 Production of high molecular mass lectins
02/06/2003WO2003010167A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands
02/06/2003WO2003010164A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
02/06/2003WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
02/06/2003WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
02/06/2003WO2003010135A1 Novel phenylpropionic acid derivatives
02/06/2003WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
02/06/2003WO2003009855A2 Organo-phosphorous compounds for activating gamma/delta t cells
02/06/2003WO2003009849A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
02/06/2003WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor
02/06/2003WO2003009836A2 New uses for 2-amino-2-propane-1,3-diols
02/06/2003WO2003009833A1 Sustained release delivery system
02/06/2003WO2003009812A2 Use of glycosylceramides as adjuvants for vaccines against infections and cancer
02/06/2003WO2003009808A2 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
02/06/2003WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/06/2003WO2003009802A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
02/06/2003WO2003009784A1 Ophthalmic drug delivery device
02/06/2003WO2003009779A2 Delivery of therapeutic capable agents
02/06/2003WO2003009778A2 Methods and devices for delivery of therapeutic capable agents with variable release profile
02/06/2003WO2003009777A2 Delivery of therapeutic capable agents
02/06/2003WO2002089773A3 Pharmaceutical compositions comprising cyclosporin
1 ... 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 ... 1172